← All trials
NCT04747574
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2020
- Primary completion
- Feb 25, 2021
- Completion date
- Mar 25, 2021
- First posted
- Feb 10, 2021
- Last posted
- Mar 4, 2021
- Enrollment
- 35
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tel Aviv UniversityLead sponsor
- Tel Aviv UniversityOverall official - principal investigator
- Tel Aviv UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.